Abstract
Objectives
To determine the characteristics and screening outcome of women referred twice at screening mammography.
Methods
We included 424,703 consecutive screening mammograms and collected imaging, biopsy and surgery reports of women with screen-detected breast cancer. Review of screening mammograms was performed to determine whether or not an initial and second referral comprised the same lesion.
Results
The overall positive predictive value of referral for cancer was 38.6% (95% CI 37.3-39.8%). Of 147 (2.6%) women referred twice, 86 had been referred for a different lesion at second referral and 32 of these proved malignant (37.2%, 95% CI 27.0-47.4%). Sixty-one women had been referred twice for the same lesion, of which 22 proved malignant (36.1%, 95% CI 24.1-48.0%). Characteristics of these women were comparable to women with cancer diagnosed after first referral. Compared with women without cancer at second referral for the same lesion, women with cancer more frequently showed suspicious densities at screening mammography (86.4% vs 53.8%, P = 0.02) and work-up at first referral had less frequently included biopsy (22.7% vs 61.5%, P = 0.004).
Conclusions
Cancer risk in women referred twice for the same lesion is similar to that observed in women referred once, or referred for a second time but for a different lesion.
Key Points
• Cancer risk was 36% for lesions referred twice at screening mammography
• The cancer risk was similar for lesions referred only once at screening
• Densities at first referral were associated with increased cancer risk at second referral
• No biopsy at first referral was associated with increased cancer risk at second referral
• Patient and tumour characteristics were similar for women with and without diagnostic delay
Similar content being viewed by others
References
Dowling E, Klabunde C, Patnick J, Ballard-Barbash R (2010) International Cancer Screening Network (ICSN) Breast and cervical cancer screening programme implementation in 16 countries. J Med Screen 17:139–146
Smith-Bindman R, Chu PW, Miglioretti DL et al (2003) Comparison of screening mammography in the United States and the United Kingdom. JAMA 290:2129–2137
Duijm LE, Groenewoud JH, de Koning HJ et al (2009) Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography. Eur J Cancer 45:774–781
Seigneurin A, Exbrayat C, Labarère J, Delafosse P, Poncet F, Colonna M (2011) Association of diagnostic work-up with subsequent attendance in a breast cancer screening program for false-positive cases. Breast Cancer Res 127:221–228
Lampic C, Thurfjell E, Bergh J, Sjödérn PO (2001) Short- and long-term anxiety and depression in women recalled after breast cancer screening. Eur J Cancer 37:436–469
Hofvind S, Thorensen S, Tretli S (2004) The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program. Cancer 101:1501–1507
van der Steeg AF, Keyzer-Dekker CM, de Vries J, Roukema JA (2011) Effect of abnormal screening mammogram on quality of life. Br J Surg 98:537–542
Duijm LE, Groenewoud JH, Fracheboud J et al (2008) Utilization and cost of diagnostic imaging and biopsies following positive screening mammography in the southern breast cancer screening region of the Netherlands, 2000-2005. Eur Radiol 18:1390–1397
Brewer NT, Salz T, Lillie SE (2007) Systematic review: the long term effects of false-positive mammograms. Ann Intern Med 146:502–510
Annual Report BOZ (Bevolkings Onderzoek Zuid) 2009, www.bevolkingsonderzoekzuid.nl/page3344/Jaarverslag
Fracheboud J, de Koning HJ, Beemsterboer PM et al (1998) Nation-wide breast cancer screening in the Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening. Int J Cancer 75:694–698
Maes RM, Dronkers DJ, Hendriks JH, Thijssen MA, Nab HW (1997) Do non-specific minimal signs in a biennial mammographic breast cancer screening programme need further diagnostic assessment? Br J Radiol 70:34–38
UICC (International Union Against Cancer) (1997) In: Sobin LH, Wittekind C (eds) TNM classification of malignant tumours, 5th edn. Wiley-Liss, New-York
American College of Radiology (2003) Breast Imaging Reporting and Data System (BI-RADS), 4th edn. American College of Radiology, Reston
Setz-Pels W, Duijm LE, Groenewoud JH et al (2011) Detection of bilateral breast cancer at biennial screening mammography in the Netherlands: a population based study. Radiology 260:357–363
Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ (1999) Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353:1119–1126
Physician Insurers Association of America (2003) Breast cancer report. Physician Insurers Association of America, Rockville
Vizcaíno I, Gadea L, Andreo L; Screening Program Working Group et al (2001) Short-term follow-up results in 795 non-palpable probably benign lesions detected at screening mammography. Radiology 219:475–483
Yasmeen S, Romano PS, Pettinger M et al (2003) Frequency and predictive value of a mammographic recommendation for short-interval follow-up. J Natl Cancer Inst 95:429–436
Rosen EL, Baker JA, Soo MS (2002) Malignant lesions initially subjected to short-term mammographic follow-up. Radiology 223:221–228
Duijm LE, Groeneveld JH, Jansen FH, Fracheboud J, van Beek M, de Koning HJ (2004) Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening. Br J Cancer 91:1795–1799
Ciatto S, Houssami N, Ambrogetti D et al (2007) Minority report-false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis. Breast Cancer Res Treat 105:37–43
Rakha EA, Lee AH, Reed J et al (2010) Screen-detected malignant breast lesions diagnosed following benign (B2) or normal (B1) needle core biopsy diagnoses. Eur J Cancer 46:1835–1840
Youk JH, Kim EK, Kim MJ, Lee JY, Oh KK (2007) Missed breast cancers at US-guided core needle biopsy: how to reduce them. Radiographics 27:79–94
Otten JD, Karssemeijer N, Hendriks JH et al (2005) Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. J Nat Cancer Inst 97:748–754
Yankaskas BC, Cleveland RJ, Schell MJ, Kozar R (2001) Association of recall rates with sensitivity and positive predictive values of screening mammography. AJR Am J Roentgenol 177:543–549
Lampic C, Thurfjell E, Bergh J, Sjödérn PO (2003) The influence of false-positive mammogram on women’s subsequent behaviour for detecting breast cancer. Eur J Cancer 39:1730–1737
Andersen SB, Vejborg I, von Euler-Chelpin M (2008) Particiaption behaviour following a false positive test in the Copenhagen mammography screening programme. Acta Oncologica 47:550–555
McCann J, Stockton D, Godward S (2002) Impact of false-positive mammography on subsequent screening attendance and risk of cancer. Breast Cancer Res 4:R11
Pinckney RG, Geller BM, Burman M, Littenberg B (2003) Effect of false-positive mammograms on return for subsequent screening mammography. Am J Med 114:120–125
Duijm LE, Groenewoud JH, Roumen RM, de Koning HJ, Plaisir M, Fracheboud J (2007) A decade of breast cancer screening in the Netherlands: trends in preoperative diagnosis of breast cancer. Breast Cancer Res Treat 106:113–119
Ciatto S, Rosselli del Turco M, Ambrogetti D et al (1997) Solid nonpalpable breast lesions. Success and failure of guided fine-needle aspiration cytology in a consecutive series of 2444 cases. Acta Radiol 38:815–820
Arisio R, Cuccorese C, Accinelli G, Mano MP, Bordon R, Fessia L (1998) Role of fine-needle aspiration biopsy in breast lesions: analysis of a series of 4,110 cases. Diagn Cytopathol 18:462–467
Pisano ED, Fajardo LL, Sneige N et al (2001) Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: results from the radiologic diagnostic oncology group. Radiology 219:785–792
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Setz-Pels, W., Duijm, L.E.M., Louwman, M.W.J. et al. Characteristics and screening outcome of women referred twice at screening mammography. Eur Radiol 22, 2624–2632 (2012). https://doi.org/10.1007/s00330-012-2523-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-012-2523-1